Parallel Advisors
SUPN icon

Parallel Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Parallel Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$904 Sell
21
-38
-64% -$1.73K ﹤0.01% 3800
2026
Q2 		$2.74K Buy
59
+38
+181% +$1.82K ﹤0.01% 3439
2026
Q1 		$1.08K Sell
21
-75
-78% -$3.82K ﹤0.01% 3531
2025
Q4 		$4.77K Buy
96
+73
+317% +$3.55K ﹤0.01% 2862
2025
Q3 		$1.1K Sell
23
-9
-28% -$362 ﹤0.01% 3198
2025
Q2 		$1.01K Buy
32
+20
+167% +$641 ﹤0.01% 3190
2025
Q1 		$393 Hold
12
– – ﹤0.01% 3274
2024
Q4 		$434 Hold
12
– – ﹤0.01% 3246
2024
Q3 		$374 Hold
12
– – ﹤0.01% 3223
2024
Q2 		$321 Hold
12
– – ﹤0.01% 3148
2024
Q1 		$409 Hold
12
– – ﹤0.01% 3086
2023
Q4 		$347 Sell
12
-56
-82% -$1.48K ﹤0.01% 3107
2023
Q3 		$1.88K Buy
68
+15
+28% +$457 ﹤0.01% 2842
2023
Q2 		$1.59K Hold
53
– – ﹤0.01% 2816
2023
Q1 		$1.92K Hold
53
– – ﹤0.01% 2792
2022
Q4 		$1.89K Sell
53
-8
-13% -$278 ﹤0.01% 2704
2022
Q3 		$2K Buy
+61
New +$1.98K ﹤0.01% 2759
2020
Q4 		– Sell
-76
Closed -$2K – 2713
2020
Q3 		$2K Hold
76
– – ﹤0.01% 2348
2020
Q2 		$1K Buy
+76
New +$1.68K ﹤0.01% 2373

Other funds holding SUPN

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Campbell Newman Asset Management
Campbell Newman Asset Management Milwaukee, Wisconsin $1.33B AUM 26.63% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Parallel Advisors's SUPN Position: Q3 2026 in Review

Parallel Advisors reduced its Supernus Pharmaceuticals (SUPN) stake by 64% in Q3 2026, selling an estimated $1.73K and leaving 21 shares worth $904. The position accounts for ﹤0.01% of the portfolio, ranked #3800.

Parallel Advisors first reported a position in SUPN in Q2 2020 and has held it in 19 quarters since. The position peaked at $4.77K in Q4 2025. 101 funds tracked by Wall St. Rank hold SUPN as of Q3 2026.

  • Parallel Advisors held 21 shares of Supernus Pharmaceuticals worth $904 as of Q3 2026.
  • Parallel Advisors sold 38 Supernus Pharmaceuticals shares in Q3 2026, an estimated $1.73K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3800 holding.
  • Parallel Advisors first reported a position in Supernus Pharmaceuticals in Q2 2020 and has held it in 19 quarters since.
  • Parallel Advisors's Supernus Pharmaceuticals position peaked at $4.77K in Q4 2025.
  • 101 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.